Revenue - Reimbursement of R and D Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Research and Development Reimbursement
Total reduction to R and D expense	$ 1,657	$ 3,301	$ 4,736	$ 5,987
Viatris
Research and Development Reimbursement
Total reduction to R and D expense	$ 1,657	1,096	$ 4,736	1,257
Janssen
Research and Development Reimbursement
Total reduction to R and D expense		$ 2,205		$ 4,730